NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
Clinical Trials
62 trialsNCT03016741 2026-02-24
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Northwestern University
Phase 4 Active not recruiting
NCT07278362 2026-02-23
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
University of Miami
Phase 4 Not yet recruiting
NCT06627530 2026-02-11
COAction
Brazilian Clinical Research Institute
Phase 4 Active not recruiting
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT07252726 2026-02-09
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT06660862 2026-01-08
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
University of Chicago
Phase 4 Not yet recruiting
NCT02651948 2025-12-19
Transperineal, MRI-guided, Prostate Biopsy
University Hospital, Strasbourg, France
Phase 4 Completed
NCT05722925 2025-11-14
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
OHSU Knight Cancer Institute
Phase 4 Active not recruiting
NCT06479187 2025-11-05
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Brigham and Women's Hospital
Phase 4 Active not recruiting
NCT06226129 2025-10-20
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Columbia University
Phase 4 Recruiting
NCT06908694 2025-07-29
GAINPCCONTROL
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT07001709 2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4 Recruiting
NCT05805436 2025-05-30
Preop Laxatives in Robotic Urologic Surgery
University of Iowa
Phase 4 Recruiting
NCT05753046 2025-04-27
TAPBlock
Corewell Health East
Phase 4 Enrolling by invitation
NCT04134208 2025-01-16
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT05568537 2025-01-03
Prostate MRI and Pylarify PSMA PET/CT
Corewell Health East
Phase 4 Withdrawn
NCT05629494 2024-10-18
ADAPT-PSA
Albany Medical College
Phase 4 Recruiting
NCT05957822 2024-05-14
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Recruiting
NCT06258486 2024-02-26
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
Kaiser Permanente
Phase 4 Unknown
NCT03432949 2024-01-24
TRANCE
University Health Network, Toronto
Phase 4 Unknown
NCT06144099 2024-01-02
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Unknown
NCT05957653 2023-07-24
Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort
RenJi Hospital
Phase 4 Unknown
NCT03796195 2023-01-25
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Northwestern University
Phase 4 Terminated
NCT05631080 2022-11-30
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
Mansoura University
Phase 4 Unknown
NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
NCT03228108 2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4 Completed
NCT05068180 2021-10-06
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
RenJi Hospital
Phase 4 Unknown
NCT04248621 2021-07-29
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Wonju Severance Christian Hospital
Phase 4 Unknown
NCT04882618 2021-05-12
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
TC Erciyes University
Phase 4 Unknown
NCT04776889 2021-03-02
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
National Cancer Institute, Egypt
Phase 4 Completed
NCT01770340 2021-02-21
Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial
Kantonsspital Winterthur KSW
Phase 4 Terminated
NCT03006562 2020-08-05
PREVENTER
Johns Hopkins University
Phase 4 Terminated
NCT02812186 2020-04-08
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Stony Brook University
Phase 4 Completed
NCT02475057 2019-06-12
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Rabin Medical Center
Phase 4 Completed
NCT00906269 2019-05-20
HBOT
Hartford Hospital
Phase 4 Unknown
NCT01136226 2018-10-24
Eligard
Chesapeake Urology Research Associates
Phase 4 Completed
NCT02818816 2018-09-27
IOPsTBURG
University Health Network, Toronto
Phase 4 Completed
NCT00859027 2018-05-01
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
UConn Health
Phase 4 Completed
NCT00245518 2017-10-13
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Johns Hopkins University
Phase 4 Completed
NCT01296672 2017-10-06
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 4 Completed
NCT03202381 2017-06-28
BLADE
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 4 Unknown
NCT01230905 2017-04-24
AST
Ottawa Heart Institute Research Corporation
Phase 4 Completed
NCT01571544 2017-01-04
The Use of Thermal Suits as Preventing Hypothermia During Surgery
Tampere University Hospital
Phase 4 Completed
NCT00220194 2016-10-14
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
San Bernardino Urological Associates Medical Group Inc
Phase 4 Completed
NCT02773251 2016-05-17
The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery
Bucheon St. Mary's Hospital
Phase 4 Completed
NCT01581749 2016-03-23
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
Main Line Health
Phase 4 Unknown
NCT02102646 2015-10-28
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Herlev Hospital
Phase 4 Completed
NCT00629330 2015-10-14
Dissemination of Prostate Cancer Screening to PCP's in African American Communities
Columbia University
Phase 4 Terminated
NCT02511665 2015-07-30
METAL
Guy's and St Thomas' NHS Foundation Trust
Phase 4 Unknown